Home - Products - Angiogenesis - Syk - Cevidoplenib dimesylate

Cevidoplenib dimesylate

Cevidoplenib dimesylate

Catalog No. M28223

Cevidoplenib dimesylate is an inhibitor of spleen tyrosine kinase (Syk), possessing anti-inflammatory and immunomodulating properties.

Size	Price / USD	Stock	Quantity
5MG	282	Get Quote
10MG	447	Get Quote
25MG	714	Get Quote
50MG	1017	Get Quote
100MG	1368	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Cevidoplenib dimesylate
Brief Description
Description
Storage
Note

Research use only, not for human use.
Reference

1.Keith Jones, et al. Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor 1. WO2015049535A1.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Amylmetacresol

Amylmetacresol is used in the treatment of sore throat or ‘acute sore throat’, pharyngitis, tonsillitis and laryngitis. As well as in the treatment of influenza A and SARS-CoV.
MNS

MNS is a tyrosine kinases inhibitor inhibits Syk Src p97 with IC50 of 2.5 μM 29.3 μM and 1.7 μM respectively.
R406

R406 is a potent Syk inhibitor with IC50 of 41 nM, strongly inhibits Syk but not Lyn, 5-fold less potent to Flt3. Phase 1.

Sign In Join Free